(Q38061933)

28 August 2017

1 reference

title

Purinergic signalling in the lower urinary tract (English)

1 reference

28 August 2017

1

G Burnstock

1 reference

28 August 2017

publication date

26 November 2012

1 reference

28 August 2017

1 reference

28 August 2017

volume

207

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

40-52

1 reference

Pharmacokinetics of intravenous ATP in cancer patients

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Pharmacologic perspective on the physiology of the lower urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Do some nerve cells release more than one transmitter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Purine-mediated signalling in pain and visceral perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Purine and pyrimidine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Physiology and pathophysiology of purinergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Purinergic mechanosensory transduction and visceral pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Acupuncture: a novel hypothesis for the involvement of purinergic signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Is there a basis for distinguishing two types of P2-purinoceptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Cellular distribution and functions of P2 receptor subtypes in different systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Evolutionary origins of the purinergic signalling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Purinergic innervation of the guinea-pig urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

ATP release from the human ureter on distension and P2X(3) receptor expression on suburothelial sensory nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

A P2X purinoceptor expressed by a subset of sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

The P2Y2 receptor sensitizes mouse bladder sensory neurons and facilitates purinergic currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Does adenosine triphosphate released into voided urodynamic fluid contribute to urgency signaling in women with bladder dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

The efficacy of acupuncture in treating urge and mixed incontinence in women: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Activation of the P2Z/P2X7 receptor in human lymphocytes produces a delayed permeability lesion: involvement of phospholipase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Purinoceptors as therapeutic targets for lower urinary tract dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Pharmacology of P2X channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Isolated human bladder: evidence for an adenine dinucleotide acting on P2X-purinoceptors and for purinergic transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Therapeutic effects of the putative P2X3/P2X2/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Endogenous purinergic control of bladder activity via presynaptic P2X3 and P2X2/3 receptors in the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

ATP is released from guinea pig ureter epithelium on distension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Evaluation of the invasive potential of superficial bladder cancer by adenosine triphosphate measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

"Thymineless" death in androgen-independent prostatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Chemotherapy induces ATP release from tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

The role of P2X7 purinergic receptors in inflammatory and nociceptive changes accompanying cyclophosphamide-induced haemorrhagic cystitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Spontaneous contractions evoke afferent nerve firing in mouse bladders with detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Mechanism of 2-chloroadenosine toxicity to PC3 cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Calcium ionophore, ionomycin inhibits growth of human bladder cancer cells both in vitro and in vivo with alteration of Bcl-2 and Bax expression levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Feed forward cycle of hypotonic stress-induced ATP release, purinergic receptor activation, and growth stimulation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Characterization of adenosine receptors in the human bladder carcinoma T24 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Effect on urinary bladder function and arterial blood pressure of the activation of putative purine receptors in brainstem areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Activation of ureter nociceptors by exogenous and endogenous ATP in guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Purinergic receptor-mediated effects of adenosine 5'-triphosphate in urological malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Differential ectonucleotidase expression in human bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Stretch-activated release of adenosine triphosphate by bladder uroepithelia is augmented in interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Apoptosis and cell death channels in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Multiple sclerosis patients with bladder dysfunction have decreased symptoms after electro-acupuncture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Mechanisms of ATP-induced calcium signaling and growth arrest in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Antiapoptotic effects of estrogen in normal and cancer human cervical epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Capacity for purinergic control of renin promoter via P2Y(11) receptor and cAMP pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

21 January 2018

P2 receptors and cancer

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Altered purinergic signaling in CD73-deficient mice inhibits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Spontaneous purinergic neurotransmission in the mouse urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12012

21 January 2018

Identifiers

DOI

10.1111/APHA.12012

1 reference

28 August 2017

1 reference